Projects (905)

I4LIFE - Indexing for life  (01/11/2010  -  31/10/2013)

IAA 2014 Additional Funding Aug 17  (01/04/2018  -  31/03/2019)

IAA 2019/20  (11/02/2019  -  31/03/2023)

IAA Impact Roadshow  (30/09/2015  -  30/09/2015)

IAA program costs  (01/04/2018  -  31/03/2019)

I am OSCAR : IBM and military open source communications analytics resesarch  (21/09/2020  -  20/10/2020)

IceMelt 200: A 200 year record of glacier melting in the Amundsen Sea  (01/03/2017  -  31/03/2018)

ICF: LIothyrONiNe Sulphate (T3S) use in hypothyroid subjects on T4 homozygous for the Thr92Ala Deiodinase2 (D2) polymorphism - the LIONNS-D2 study  (01/05/2023  -  30/04/2026)

iCOAST:Integrated COASTal sediment systems  (01/02/2012  -  30/04/2016)

ICS  (01/10/2016  -  31/12/2022)

IDEA factory - Curative resilience scoping study  (01/09/2010  -  31/12/2011)

IDEA - Integrated DEmentiA research environment  (01/04/2015  -  31/03/2016)

Idebenone in mitochondrial optic neuropathy  (01/06/2013  -  30/09/2014)

Identification and analysis of genomic programme for cardiac specification  (01/03/2012  -  30/04/2015)

Identification and characterisation of Toll-like receptor 2 extracellular domain-derived fragments capable of modulating bacterial-induced pro-inflammatory responses in vitro and in vivo  (01/06/2004  -  31/05/2008)

Identification and function of sex pheromones and their receptors in Drosophila  (01/03/2010  -  28/02/2013)

Identification and management of patients at risk outcome and vascular events in peritoneal dialysis  (01/01/2019  -  30/06/2023)

Identification and Mitigation of Sub and near-Synchronous Oscillations (IMSSO) instability in the BG network  (01/01/2020  -  31/12/2022)

Identification and quantification of g3 gas arcing by-products and their implication for GIS operation  (01/11/2022  -  31/03/2026)

Identification and validation of method(s) to describe antimicrobial resistance development  (01/10/2010  -  30/09/2013)

Identification, design and planning for the installation of technology to process residual materials arising from the Company's material recovery facility  (17/02/2011  -  16/02/2013)

Identification of Bacterial Post-translational Modifications that Regulate Antimicrobial Resistance  (01/10/2018  -  31/03/2022)

Identification of best practice in joint scrutiny arrangements across Wales and the production of a practitioner's toolkit  (01/11/2013  -  30/09/2014)

Identification of brain-penetrant complement membrane attack inhibitors for therapy of dementia.  (01/05/2023  -  30/09/2025)

Identification of chemotypes selectively binding to a structured motif of IncRNA NEAT1 as templates for novel drugs  (01/09/2019  -  31/08/2021)

Identification of coding variants in DNA repair genes affecting age at onset of Huntington's disease  (01/08/2016  -  31/10/2017)

Identification of drug-­‐drug interaction for a novel anti-­‐metastatic small molecule inhibitor  (01/07/2020  -  30/04/2021)

Identification of genetic modifiers in Huntington's disease  (01/03/2016  -  30/04/2018)

Identification of genome-wide targets for neurodevelopment  (01/10/2012  -  30/09/2013)

Identification of immune cell subsets with heightened cellular turnover and signs of biological ageing in severe myalgic encephalitis/chronic fatigue syndrome  (13/01/2020  -  31/01/2021)

Identification of long range outdoor sugar feeding cues for the malaria pathogen vector Anopheles gambiae  (01/10/2020  -  28/02/2026)

Identification of mechanisms underpinning regulatory T cell involvement in disease  (01/02/2009  -  31/10/2015)

Identification of metabolomic signatures of variation in thyroid status  (01/10/2018  -  31/10/2020)

Identification of novel antihormone-induced pro-survival genes in oestrogen receptor - positive breast cancer  (01/11/2012  -  31/10/2015)

Identification of novel C3bBb convertase inhibitors for the treatment of neurodegenerative diseases  (01/04/2021  -  31/12/2022)

Identification of novel candidate genes in dystonia-plus disorders  (26/08/2014  -  31/12/2016)

Identification of novel colorectal cancer diagnostic markers through exploration of chromosome interactions accompanying malignant progression - Studentship  (01/10/2023  -  30/09/2026)

Identification of novel drug-radiation enhancers in an ex vivo lung cancer model  (01/10/2018  -  30/06/2022)

Identification of novel infantile epileptic encephalopathy genes by exomic sequencing  (01/02/2013  -  31/07/2016)

Identification of novel tumour associated antigens in Glioblastoma to improve anti-tumour T-cell responses  (01/05/2025  -  31/07/2027)

Identification of pathofenicity genes in Group B Streptococci isolated from the blood of sepsis patients in UK  (01/10/2017  -  30/09/2018)

Identification of positive allosteric modulators of serine racemase and mechanistic insights into SR regulation  (01/09/2019  -  31/08/2020)

Identification of regional areas for the national development framework  (13/02/2017  -  01/11/2017)

Identification of selective positive modulators of GlyRα3 for the treatment of neuropathic and inflammatory pain  (01/06/2021  -  31/08/2021)

Identification of small molecules capable of removing ageing cells and slowing down the ageing process  (01/09/2012  -  30/06/2015)

Identification of the gene for Motor Neurone Disease and fronto-temporal dementia linked to chromosome 9  (01/05/2010  -  30/04/2013)

Identification of the molecular defects associated with CDKL5 deficiency  (01/08/2014  -  30/04/2016)

Identification of the molecular defects in metabolic pathways associated with MECP2 deficiency  (01/07/2013  -  30/06/2014)

Identification of the molecular mechanisms underlying disease variation, severity and progression in Parkinson’s disease using cohorts of deeplyphenotyped patients and human induced pluripotent stem cell models  (01/06/2019  -  31/03/2023)